ESG Controversy Top Movers
Week ending July 16th, 2023
In this week's report:
- US-based equipment vendor Lam Research loses infringement court case to China's leading semiconductor equipment maker;
- Illumina, Bank of America hit by hefty fines from regulators;
- Haleon, Freightos to cut staff significantly and
- HCA Healthcare reports breach of 11M patients' data.
The EU fined the U.S. genetic sequencing giant Illumina with $475 million for the acquisition of cancer detection company Grail without regulatory approval.
Bank of America to pay over $100 million after doubling fees and opening accounts without customer consent.
HCA Healthcare reports breach of 11 million patients’ personal data.
Italian luxury brand Bulgari apologized to China after listing Taiwan as a country on its website.
METAMeta Platforms Inc.
Meta faces a class lawsuit for AI products infringing authors' rights.
Telecom group Altice's co-founder Armando Pereira has been detained for alleged corruption, tax fraud and money laundering.
Haleon, the company behind the Sensodyne toothpaste and Advil painkillers, is planning to cut hundreds of roles in the UK and potentially thousands worldwide.
US-based equipment vendor Lam Research loses infringement court case to China's leading semiconductor equipment maker Advanced Micro-fabrication Equipment (AMEC).
Aziyo Biologics, a company that develops biologic products, announceçd a voluntary recall of bone repair products, after reported infections in patients.
Freightos, a digital marketplace for international air and ocean shipping, will reduce staff by 13%.
It's often difficult to follow all the news to build a complete picture about a company, particularly when events are less reported. Yet published research has identified how selecting stocks and bonds with low controversy profile captures more alpha and lowers risk.
Leveraging local and global newswire coverage, the RavenPack controversy framework allows investors to identify companies involved in controversial events. Each week we publish a selection of controversy identified on a different universe.